Latest Updates
-
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet -
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens -
The Sunscreen Confusion: Expert Explains How to Choose What Actually Works in Indian Weather -
On Goa Liberation Day 2025, A Look At How Freedom Shaped Goa Into A Celebrity-Favourite Retreat -
Daily Horoscope, Dec 19, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs
Protein That Prevents Cancer Found
Researchers from the University of Texas M. D. Anderson Cancer Centre have found that a protein previously suspected in inhibiting DNA repair actually promotes it and prevents cancer.
The protein, HMGB1 has long been known to attach to sites of damaged DNA and was believed to prevent DNA repair.
"That did not make sense to us, because HMGB1 is a chromosomal protein that's so abundant that it would be hard to imagine cell repair happening at all if that were the case," said Vasquez.
During the study, Vasquez and Sabine Lange, a doctoral candidate in the Graduate School of Biomedical Sciences analysed the protein's impact on DNA restoration that includes access to damage, repair and repackaging of the original structure, a combination of DNA and histone proteins called chromatin.
First, they knocked out the gene mouse embryonic cells and then exposed cells to two types of DNA-damaging agents. One was UV light, the other a chemotherapy called psoralen that's activated by exposure to darker, low frequency light known as UVA.
In both cases, the cells survived at a steeply lower rate after DNA damage than did normal cells.
Later they exposed HMGB1 knockout cells and normal cells to psoralen and assessed the rate of genetic mutation.
The knockout cells had a mutation frequency more than double that of normal cells, however, there was no effect on the types of mutation that occurred.
Knock out and normal cells were then exposed to UV light and suffered the same amount of damage. However, those with HMGB1 had two to three times the repair as those without.
Vasquez said that this showed that HMGB1 worked by summoning other DNA repair factors to the damaged site,.
However, HMGB1's role in repair is crucial to drugs under development to block the protein, Vasquez said.
The protein also plays a role in inflammation, so it's being targeted in drugs under development for rheumatoid arthritis and sepsis.
"Arthritis therapy involves long-term treatment," Vasquez said. "Our findings suggest that depleting this protein may leave patients more vulnerable to developing cancer."
The study appears online this week in the Proceedings of the National Academies of Science.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











